Results for daunorubicin translation from English to Dutch

daunorubicin
daunorubine

daunorubicin, doxorubicin, paclitaxel, or topotecan for cancer
daunorubicine, doxorubicine, paclitaxel of topotecan voor kanker

daunorubicin 45 mg/ m2 i.v., days 6-7, 13-14
daunorubicine 45 mg/m2 i.v., dag 6-7, 13-14

daunorubicin 30 mg/m2 i.v., days 1-3, 15-16;
daunorubicine 30 mg/m2 i.v., dag 1-3, 15-16; vcr

daunorubicin 30 mg/m2 i.v., days 1-3, 15-16; v
daunorubicine 30 mg/m² i.v., dag 1-3, 15-16;

daunorubicin, doxorubicin, imatinib, irinotecan, lapatinib, mitoxantrone, topotecan concentrations may increase.
er kunnen stijgingen in de plasmaconcentraties van daunorubicine, doxorubicine, imatinib, irinotecan, lapatinib, mitoxantron en topotecan optreden.

metformin, used for diabetes, daunorubicin, doxorubicin, imatinib, irinotecan, lapatinib, mitoxantrone, topotecan, used for different sorts of cancer.
metformine, gebruikt bij diabetes; daunorubicine, doxorubicine, imatinib, irinotecan, lapatinib, mitoxantron of topotecan, gebruikt bij verschillende soorten kanker.

daunorubicin, doxorubicin, imatinib, irinotecan, lapatinib, mitoxantrone or topotecan: careful monitoring for any occurrence of drug toxicity, and dose reduction if required.
daunorubicine, doxorubicine, imatinib, irinotecan, lapatinib, mitoxantron of topotecan: nauwkeurige monitoring van het optreden van geneesmiddeltoxiciteit en, indien nodig, verlaging van de dosering.

emetogenic chemotherapies administered included doxorubicin, cyclophosphamide (<1500 mg/m2), ifosfamide, cisplatin, dactinomycin, carboplatin, and daunorubicin.
de emetogene chemotherapie die werd toegediend, bestond uit doxorubicine, cyclofosfamide (<1500 mg/m²), ifosfamide, cisplatine, dactinomycine, carboplatine en daunorubicine.

daunorubicin 30 mg/ m2 i. v., days 1-3, 15-16; vcr 2 mg total dose i. v., days 1, 8, 15, 22; cp 750 mg/ m2 i. v., days 1, 8; prednisone 60 mg/ m2 oral, days 1-7, 15-21; ida 9 mg/ m2 oral, days 1-28; mtx 15 mg intrathecal, days 1, 8, 15, 22; ara-c 40 mg intrathecal, days 1, 8, 15, 22; methylprednisolone 40 mg intrathecal, days 1, 8, 15, 22
dag 1, 8, 15, 22; cp 750 mg/ m2 i. v., dag 1, 8; prednison 60 mg/ m2 oraal, dag 1-7, 15-21; ida 9 mg/ m2 oraal, dag 1-28; mtx 15 mg intrathecaal, dag 1, 8, 15, 22; ara-c 40 mg intrathecaal, dag 1, 8, 15, 22; methylprednisolon 40 mg intrathecaal, dag 1, 8, 15, 22